MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$101,146
Unit: Dollar

Unit: Dollar
Income Statement
2025-12-31
Revenues
0
Selling, general and administrative
154,024
Total operating expenses
154,024
Loss from operations
-154,024
Liability forgiveness
62,032
Interest expense - related parties
9,154
Total other expenses
52,878
Loss before income tax expense
-101,146
Income tax expense
0
Net loss
-101,146
Basic and diluted loss per share of common stock
0
Weighted average number of shares of common stock outstanding
60,042,000
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$101,146 Liability forgiveness$62,032 Loss before incometax expense-$101,146 Total other expenses$52,878 Interest expense -related parties$9,154 Loss from operations-$154,024 Total operatingexpenses$154,024 Selling, general andadministrative$154,024

ACRO BIOMEDICAL CO., LTD. (ACBM)

ACRO BIOMEDICAL CO., LTD. (ACBM)